Back
ARS Pharmaceuticals 10K Form
Sell
35
SPRY
ARS Pharmaceuticals
Last Price:
14.87
Seasonality Move:
-2.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SPRY News And Ratings
See the #1 stock for the next 7 days that we like better than SPRY
SPRY Financial Statistics
Sales & Book Value
| Annual Sales: | $30K |
|---|---|
| Cash Flow: | $-7.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.22 |
| Price / Book: | 6.33 |
Profitability
| EPS (TTM): | -0.47000 |
|---|---|
| Net Income (TTM): | $-44.84M |
| Gross Margin: | -- |
| Return on Equity: | -19.4% |
| Return on Assets: | -18.84% |
ARS Pharmaceuticals Earnings Forecast
Key ARS Pharmaceuticals Financial Ratios
- The Research & Development expenses have been 67,553.33% of Revenue.
- The Net Earning history of SPRY is -181,216.67% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
ARS Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SPRY |
| Website: | ars-pharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 32.82 |
| Quick Ratio: | 32.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SPRY Technical Analysis vs Fundamental Analysis
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
Is ARS Pharmaceuticals a Buy or a Sell?
-
ARS Pharmaceuticals stock is rated a Sell
The current ARS Pharmaceuticals [SPRY] share price is $14.05. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.